Standout Papers

Results of the CONFIRM Phase III Trial Comparing Fulvestrant 250 mg With Fulvestrant 500 mg in Po... 2010 2026 2015 2020 443
  1. Results of the CONFIRM Phase III Trial Comparing Fulvestrant 250 mg With Fulvestrant 500 mg in Postmenopausal Women With Estrogen Receptor–Positive Advanced Breast Cancer (2010)
    Angelo Di Leo, Guy Jérusalem et al. Journal of Clinical Oncology

Citation Impact

1 by Nobel laureates 3 from Science/Nature 104 standout
Sub-graph 1 of 19

Citing Papers

Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer
2024 Standout
A new era of cancer phototherapy: mechanisms and applications
2024 Standout
5 intermediate papers

Works of Roberto Torres being referenced

Comparing duration of response and duration of clinical benefit between fulvestrant treatment groups in the CONFIRM trial: application of new methodology
2013
Results of the CONFIRM Phase III Trial Comparing Fulvestrant 250 mg With Fulvestrant 500 mg in Postmenopausal Women With Estrogen Receptor–Positive Advanced Breast Cancer
2010 Standout

Author Peers

Author Oncology PRM Genetics Last Decade Papers Cites
Roberto Torres 558 523 298 20 781
R. Rajesh Babu 1 10 331
G. P. Wong 3 12 435
Susan D. Collins 19 2 15 145
So Won Kim 116 44 26 30 369
Anna Neukirch 3 7 418

All Works

Loading papers...

Rankless by CCL
2026